Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia

References

• Wolfe F, Hawley DJ, Goldenberg DL, et al. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 2000;27:1989-99
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72
   PubMed Web of Science ®Google Scholar
• NIAMS. Fibromyalgia. 1999. Available at: http://www.niams.nih.gov/Health_Info/Fibromyalgia/default.asp [Last accessed 5 May 2009]
   Google Scholar
• Topbas M, Cakirbay H, Gulec H, et al. The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol 2005;34:140-4
   PubMed Web of Science ®Google Scholar
• Weir PT, Harlan GA, Nkoy FL, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006;12:124-8
   PubMed Web of Science ®Google Scholar
• Toda K. The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol 2007;36:140-4
   PubMed Web of Science ®Google Scholar
• Mas AJ, Carmona L, Valverde M, et al. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 2008;26:519-26
   PubMed Web of Science ®Google Scholar
• NFA. Prevalence of Fibromyalgia. 2009. Available at: http://www.fmaware.org/site/PageServer?pagename=fibromyalgia_affected [Last accessed 5 May 2009]
   Google Scholar
• WD. Prevalence and Incidence of Fibromyalgia. Available at: http://www.wrongdiagnosis.com/f/fibromyalgia/stats.htm [Last accessed 5 May 2009]
   Google Scholar
• Wolfe F, Petri M, Alarcon GS, et al. Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity. J Rheumatol 2009;36:82-8
   PubMed Web of Science ®Google Scholar
• Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2009;39:448-53
   Google Scholar
• Bannwarth B, Blotman F, Roue-Le Lay K, et al. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 2009;76:184-7
   PubMed Web of Science ®Google Scholar
• Schochat T, Raspe H. Elements of fibromyalgia in an open population. Rheumatology (Oxford) 2003;42:829-35
   PubMed Web of Science ®Google Scholar
• Bazelmans E, Vercoulen JH, Galama JM, et al. [Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in The Netherlands]. Ned Tijdschr Geneeskd 1997;141:1520-3
   PubMedGoogle Scholar
• Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17
   PubMed Web of Science ®Google Scholar
• Sardini S, Ghirardini M, Betelemme L, et al. [Epidemiological study of a primary fibromyalgia in pediatric age]. Minerva Pediatr 1996;48:543-50
   PubMedGoogle Scholar
• Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28
   PubMed Web of Science ®Google Scholar
• Buskila D, Neumann L, Hershman E, et al. Fibromyalgia syndrome in children – an outcome study. J Rheumatol 1995;22:525-8
   PubMed Web of Science ®Google Scholar
• Al-Allaf AW. Work disability and health system utilization in patients with fibromyalgia syndrome. J Clin Rheumatol 2007;13:199-201
   PubMed Web of Science ®Google Scholar
• Robinson RL, Jones ML. In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review. Expert Opin Pharmacother 2006;7:1027-39
   PubMed Web of Science ®Google Scholar
• Bennett RM, Jones J, Turk DC, et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007;8:27
   PubMed Web of Science ®Google Scholar
• Shaver JL, Wilbur J, Robinson FP, et al. Women’s health issues with fibromyalgia syndrome. J Womens Health (Larchmt) 2006;15:1035-45
   PubMed Web of Science ®Google Scholar
• Rutledge DN, Jones K, Jones CJ. Predicting high physical function in people with fibromyalgia. J Nurs Scholarsh 2007;39:319-24
   PubMed Web of Science ®Google Scholar
• Berger A, Dukes E, Martin S, et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 2007;61:1498-508
   PubMed Web of Science ®Google Scholar
• Panton LB, Kingsley JD, Toole T, et al. A comparison of physical functional performance and strength in women with fibromyalgia, age- and weight-matched controls, and older women who are healthy. Phys Ther 2006;86:1479-88
   PubMed Web of Science ®Google Scholar
• Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes 2008;6:8
   PubMed Web of Science ®Google Scholar
• Kurtze N, Gundersen KT, Svebak S. Quality of life, functional disability and lifestyle among subgroups of fibromyalgia patients: the significance of anxiety and depression. Br J Med Psychol 1999;72(Pt 4):471-84
   PubMedGoogle Scholar
• White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008;50:13-24
   PubMed Web of Science ®Google Scholar
• Hauser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome – a systematic review. Eur J Pain 2009;14:5-10
   Google Scholar
• Sumpton JE, Moulin DE. Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Res Manag 2008;13:477-83
   PubMed Web of Science ®Google Scholar
• Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67:536-41
   PubMed Web of Science ®Google Scholar
• Guymer EK, Littlejohn GO. Fibromyalgia. Diagnosis and management. Australas Chiropr Osteopathy 2002;10:81-4
   PubMedGoogle Scholar
• Garcia-Campayo J, Serrano-Blanco A, Rodero B, et al. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. Trials 2009;10:24
   PubMed Web of Science ®Google Scholar
• Russell IJ, Mease PJ, Smith TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008;136:432-44
   PubMed Web of Science ®Google Scholar
• Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5-15
   PubMed Web of Science ®Google Scholar
• Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73
   PubMed Web of Science ®Google Scholar
• Calandre EP, Morillas-Arques P, Rodriguez-Lopez CM, et al. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial. Pharmacopsychiatry 2007;40:68-71
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Mease PJ, Simpson SL, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008;136:419-31
   PubMed Web of Science ®Google Scholar
• Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35:502-14
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008;30:1988-2004
   PubMed Web of Science ®Google Scholar
• Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975-85
   PubMed Web of Science ®Google Scholar
• Vitton O, Gendreau M, Gendreau J, et al. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004;19(Suppl 1):S27-35
   PubMed Web of Science ®Google Scholar
• Zhao Y, Sun P, Watson P, et al. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia. Pain Pract 2011;11:204-16
   PubMed Web of Science ®Google Scholar
• Lilly. Cymbalta Package Insert. 2004. Available at: http://pi.lilly.com/us/cymbalta-pi.pdf [Last accessed 9 March 2011]
   Google Scholar
• Pfizer. Lyrica Package Insert. 2004. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=31444#nlmhighlights [Last accessed 9 March 2011]
   Google Scholar